Skip to main content

Advertisement

SpringerLink
Log in

Surveillance for Low-Grade Dysplastic Barrett’s Oesophagus: One Size Fits All?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

This paper reviews the role of low-grade dysplasia (LGD) as a marker of progression in Barrett’s oesophagus (BO). Albeit with its limits due to the difficulty of its diagnosis and the low agreement among pathologists, LGD remains the most relevant single prognostic factor of progression, and, when the diagnosis is confirmed by two or three pathologists, the chances of progression to high-grade dysplasia or invasive adenocarcinoma are as high as 40 %. On the other hand, BO patients who remain dysplasia free at several follow-up examinations seem to have a very low likelihood of progression. The diagnosis of LGD should be confirmed by two pathologists, and surveillance programs should be tailored depending on the presence or persistent absence of LGD. Ablative therapy should be also considered for cases where LGD persists in a series of follow-ups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jung KW, Talley NJ, Romero Y et al (2011) Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol 106:1447–1455

    Article  PubMed Central  PubMed  Google Scholar 

  2. Hvid-Jensen F, Petersen L, Drewes AM, Sorensen HT, Fuch-Jensen P (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365:1375–1383

    Article  CAS  PubMed  Google Scholar 

  3. Solaymani-Dodaran M, Logan RF, West J et al (2004) Risk of oesophageal cancer in Barrett’s esophagus and gastro-oesophageal reflux. Gut 53:1070–1074

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Spechler SJ, Sharma P, Souza RF et al (2011) American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140(3):1084–1091

    Article  PubMed  Google Scholar 

  5. Ryce TW, Rusch VW, Ishwaran H, Blackstone EH (2010) Cancer of the esophagus and of the esophagogastric junction. Data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manual. Cancer 116:3673–3676

    Google Scholar 

  6. Bennett C, Green S, DeCaestecker J, Almond M, Barr H, Bhandari P, Ragunath K, Singh R, Jankowski J (2012) Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett’s oesophagus. Cochrane Database Syst Rev 11:CD007334

    PubMed  Google Scholar 

  7. Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797

    Article  PubMed  Google Scholar 

  8. Standards of Practice Committee, Evans JA, Early DS, Fukami N et al (2012) The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 76(6):1087–1094

    Article  Google Scholar 

  9. British Society of Gastroenterology (BSG). BSG guidelines for the diagnosis and management of columnar lined oesophagus. A report of the working party of the British Society of Gastroenterology. http://www.bsg.org.uk/pdf_word_docs/Barretts_Oes.pdf. Accessed 08 June 2014

  10. Fitzgerald RC, di Pietro M, Ragunath K et al (2014) British society of gastroenterology guidelines on the diagnosis and management of Barrett’s esophagus. Gut 63(1):7–42

    Article  PubMed  Google Scholar 

  11. Boyer J, Laugier R, Chemali M et al (2007) French society of digestive endoscopy SFED guideline: monitoring of patients with Barrett’s esophagus. Endoscopy 39:840–842

    Article  CAS  PubMed  Google Scholar 

  12. Shaheen NJ, Werinberg DS, Denberg TD et al (2012) Upper endoscopy for gastroesophageal reflux disease: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 39:840–842

    Google Scholar 

  13. Thomson S, Foubister T, Mossialos E (2009) Financing health care in the European Union: challenges and policy responses. www.euro.who.int/__data/assets/pdf_file/0009/98307/E92469.pdf. Accessed 15 Jan 2014

  14. Inadomi JM, Sampliner R, Lagergreen J, Liebermann D, Fendrick M, Vakil N (2003) Screening and surveillance for Barrett’s esophagus in high risk patient: a cost utility analysis. Ann Intern Med 138:176–186

    Article  PubMed  Google Scholar 

  15. Garside R, Pitt M, Somerville M et al (2006) Surveillance of Barrett’s oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modeling. Health Technol Assess 10:8

    Article  Google Scholar 

  16. Choi SE, Hur C (2012) Screening and surveillance in barrett’s esophagus: current issues and future directions. Curr Opin Gastroenterol 28:377–381

    Article  PubMed Central  PubMed  Google Scholar 

  17. Iftikhar SY, James PD, Steele J, Hardcastle D et al (1992) Length of Barrett’s oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33:1155–1158

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Prasad GA, Bansal A, Sharma P, Wang KW (2010) Predictors of progression in Barrett’s esophagus: current knowledge and future directions. Am J Gastroenterol 105:1490–1502

    Article  PubMed Central  PubMed  Google Scholar 

  19. Schempler RJ, Riddell RH, Kato Y et al (2000) The Vienna classification of intraepithelial neoplasia. Gut 47:251–255

    Article  Google Scholar 

  20. Nasr JY, Schoen RE (2011) Prevalence of adenocarcinoma at esophagectomy for Barrett’s esophagus with high-grade dysplasia. J Surg Oncol 2:34–38

    Google Scholar 

  21. Rastogi A, Puli S, El-Serag HB et al (2008) Incidence of adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia. Gastrointest Endosc 67:394–398

    Article  PubMed  Google Scholar 

  22. Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on Delphi process. Gastroenterology 143:336–346

    Article  PubMed  Google Scholar 

  23. Gaddam S, Singh M, Balasubramanian G et al (2013) Persistence of nondysplastic Barrett’s esophagus identifies patients at lower risk for esophageal adenocarcinoma: result from a large multicentre cohort. Gastroenterology 145:548–553

    Article  PubMed  Google Scholar 

  24. Gatenby P, Ramus J, Caygill C, Shepherd N, Winslet M, Watson A (2009) Routinely diagnosis of low grade dysplasia in Barrett esophagus. A population-based study of natural story. Histopathol 54:814–819

    Article  Google Scholar 

  25. Lim CH, Treanor D, Dixon MF, Axon AT (2007) Low-grade dysplasia Barrett’s esophagus has a great risk of progression. Endoscopy 207:581–587

    Article  Google Scholar 

  26. Rugge M, Zaninotto G, Parente P, Zanatta L et al (2012) Barrett’s esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry. Ann Surg 256:788–795

    Article  PubMed  Google Scholar 

  27. Wani S, Puli SR, Shaheen SR et al (2009) Esophageal adenocarcinoma in Barrett’s esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 104:502–513

    Article  PubMed  Google Scholar 

  28. Bhat S, Coleman HG, Yousef F et al (2011) Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057

    Article  PubMed Central  PubMed  Google Scholar 

  29. Sharma G, Falk GW, Weston AP, Reker D, Johnston D, Sampliner RE (2006) Dysplasia and cancer in a large multicentre cohort of patients with Barrett’s esophagus Clin Gastroenterol Hepathol 4:566–572

    Google Scholar 

  30. Wani S, Falk GW, Post J, Yerian L (2011) Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology 141:1179–1186

    Article  PubMed  Google Scholar 

  31. Rossi M, Barreca M, DeBortoli N, Renzi C et al (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett’s esophagus: a prospective study. Ann Surg 243:58–63

    Article  PubMed Central  PubMed  Google Scholar 

  32. Odze RD, Goldblum JR (2006) Low-grade dysplasia in Barrett’s Esophagus (letter). Clin Gastroenterol Hepatol 4:1419–1421

    Article  PubMed  Google Scholar 

  33. Kerkhof M, van Dekken H, Steyerberg EW, Meijer GA et al (2007) Grading of dysplasia in Barrett’s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50:920–927

    Article  CAS  PubMed  Google Scholar 

  34. Kaye PV, Haider SA, Ilyas M, James PD et al (2009) Barrett’s dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry. Histopathology 54:699–712 Erratum appears in Histopathology 2009;54(7):917

    Article  PubMed  Google Scholar 

  35. Voltaggio L, Montgomery EA, Lam-Himlin D (2011) A clinical and pathological focus on Barrett esophagus and Barrett-related dysplasia. Arch Pathol Lab Med 135:1249–1260

    Article  PubMed  Google Scholar 

  36. Sonwalkar SA, Rotini O, Scott N et al (2010) A study of indefinite for dysplasia in Barrett’s esophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (α-methylacyl-coA-racemase). Histopathology 56:906–907

    Article  Google Scholar 

  37. Curvers WL, ten Kate FJ, Khrisnadath KK et al (2010) Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol 105:1523–1530

    Article  PubMed  Google Scholar 

  38. Skacel M, Petras RE, Gramlich TL, Sigel J, Richter JE, Goldblum JR (2000) The diagnosis of low- grade dysplasia in Barrett’s esophagus and its implication on disease progression. Am J Gastroenterol 95:3383–3387

    Article  CAS  PubMed  Google Scholar 

  39. Srivastava A, Hornick JL, Li X et al (2007) Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett’s esophagus. Am J Gastroenterol 102:483–493

    Article  PubMed  Google Scholar 

  40. Buttar N, Wang K, Sebo TJ et al (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with the risk of adenocarcinoma. Gastroenterology 120:1630–1639

    Article  CAS  PubMed  Google Scholar 

  41. Dar MS, Goldblum JR, Rice TW, Falk GW (2003) Can extent of high-grade dysplasia in Barrett’s oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut 52:486–489

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Younes M, Lawers GY, Ertan A et al (2001) The significance of “indefinite for dysplasia” grading in Barrett’s esophagus. Arch Pathol Lab Med 135:430–432

    Google Scholar 

  43. Aldulaimi DM, Cox M, Nwokolo CU, Loft DE (2005) Barrett’s surveillance is worthwhile and detects curable cancer. A prospective cohort study addressing cancer incidence, treatment, outcome and survival. Eur J Gastroenterol Hepatol 17:943–950

    Article  PubMed  Google Scholar 

  44. Wani S, Falk G, Hall M, Gaddam S (2011) Patients with non-dysplastic Barrett’s esophagus have a low risk for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol 9:220–227

    Article  PubMed  Google Scholar 

  45. Yousef F, Cardwell C, Cantwell M et al (2008) The incidence of esophageal cnacer and high grade dysplasia in Barrett’s esophagus. Am J Epidemiol 168:237–249

    Article  PubMed  Google Scholar 

  46. Patil DT, Plesec T, Goldblum JR (2011) Low prevalence of invasive adenocarcinoma and occult cancer on esophaheal resection for Barrett’s Esophagus with high grade dysplasia; evidence for a conservative management. J Gastrointest Oncol 2:5–7

    PubMed Central  PubMed  Google Scholar 

  47. Reid BJ, Levine DS, Longton G et al (2000) Predictors of progression to cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95(7):1669–1676

    PubMed Central  CAS  PubMed  Google Scholar 

  48. Montgomery E, Bronner MP, Goldblum JR, Greenson JK et al (2001) Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Human Pathol 32:368–378

    Article  CAS  Google Scholar 

  49. Menon D, Stafinsky T, Heng W, Lau D, Wong C (2010) Endoscopic treatment for Barrett’s esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterol 10:111–133

    Article  PubMed Central  PubMed  Google Scholar 

  50. Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288

    Article  CAS  PubMed  Google Scholar 

  51. Hur C, Choi SE, Rubenstein JL et al (2012) The cost effectiveness of radiofrequency ablation for Barrett’s esophagus. Gastroenterology 143:567–575

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Cancer, St Mary’s Hospital, Imperial College, London, UK

    Giovanni Zaninotto

  2. Evidence Based Medicine, Faculty of Medicine, University of Plymouth, Plymouth, UK

    Cathy Bennett

Authors
  1. Giovanni Zaninotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cathy Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Zaninotto.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaninotto, G., Bennett, C. Surveillance for Low-Grade Dysplastic Barrett’s Oesophagus: One Size Fits All?. World J Surg 39, 578–585 (2015). https://doi.org/10.1007/s00268-014-2661-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-014-2661-5

Keywords

Search

Navigation